Dr. Antonio Wolff is internationally recognized for his work on breast cancer biomarkers, including HER2. As a practicing oncologist and clinical translational researcher, his research has been pivotal to improve the quality of breast cancer biomarker testing in breast cancer, including HER2 and estrogen receptor testing. Among his leadership accomplishments is ensuring that sophisticated laboratory findings are translated into improved clinical care in breast cancer. He is a Fellow of the American Society of Clinical Oncology (ASCO), a Komen Scholar and a Breast Cancer Research Foundation investigator. He has served as associate editor for Journal of Clinical Oncology, and serves on the National Comprehensive Cancer Network (NCCN) Guideline Steering Committee. He is a leader of the Translational Breast Cancer Research Consortium (TBCRC), and one of the principal investigators of the Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE) in Metastatic Breast Cancer, which was one of the three disease groups recently awarded by ARPA-H to conduct innovative trials using Advanced Analysis for Precision Cancer Therapy (ADAPT). After many years of service as Breast Committee Chair in the ECOG-ACRIN Clinical Trial Network of the National Cancer Institute (NCI), he was elected in 2024 as Co-Chair of the NCI Breast Cancer Steering Committee and appointed to the international steering committee of the Oxford Overview Collaborative, which are positions aimed at advancing clinical trials in breast cancer. At Johns Hopkins, he is an elected member of the Miller Coulson Academy of Clinical Excellence and was honored during the 125th Anniversary Living the Hopkins Mission celebrations of the JHU School of Medicine. Dr. Wolff is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer.

Dr. Santa-Maria completed his oncology training at Johns Hopkins, and has been focused on caring for patients with breast cancer since then. He works as both a primary oncologist and consultant for patients with all types and stages of breast cancer. His research interest is in developing new types of treatment for patients with breast cancer using immunotherapy. Dr. Santa is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast.

Sandra Swain is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Swain is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, HER-2 Positive Breast Cancer, and Febrile Neutropenia.

Roisin Connolly is an Oncologist in Baltimore, Maryland. Dr. Connolly is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Tissue Biopsy.

Dr. Visvanathan is a Professor on faculty at Johns Hopkins. She is a practicing medical oncologist and cancer epidemiologist focused on translating discoveries to the clinic and population as a whole. She directs the Clinical Cancer Genetics and Prevention service at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (SKCCC) and is an active member of the Breast and Ovarian Program and Cancer Prevention and Control Program. Dr. Visvanathan is also Director of the Cancer Epidemiology Track in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. With her research centered on primary and secondary prevention of breast and ovarian cancer, her goal is to reduce the incidence of and mortality from breast cancer globally by conducting impactful studies at the local, national, and international levels. Specifically, she focuses on the identification of atrisk groups, potential biomarkers of risk and prognosis and evaluation of preventive agents across the continuum. She conducts both observational studies and early phase clinical trials. She also teaches and mentors the next generation of clinicians and cancer researchers. Dr. Visvanathan has also served on national committees focused on Breast Cancer Risk Reduction, Breast Cancer Genetics and Cancer Disparities. She has also co-chaired National Guidelines on Breast Cancer Endocrine Prevention. Locally, serving on the Maryland State Cancer Council. Dr. Visvanathan received her medical degree from the University of Sydney in Australia. She subsequently went on to complete training in internal medicine and medical oncology, including a period as chief resident at Royal Prince Alfred Hospital. She then did further training in Medical Oncology at Johns Hopkins and also obtained a master’s degree in clinical/cancer epidemiology at Johns Hopkins Bloomberg School of Public Health. This was followed by a postdoctoral fellow before coming on to faculty in both the Johns Hopkins School of Medicine and Bloomberg School of Public Health. Dr. Visvanathan is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Ovarian Cancer, Menopause, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

David Euhus is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Euhus is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Mastectomy, and Lymphadenectomy.

Craig Shriver is a Surgical Oncologist and a General Surgeon in Bethesda, Maryland. Dr. Shriver is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Breast Cancer in Men, Colorectal Cancer, Mastectomy, and Thyroidectomy.

Katherine Tkaczuk is an Oncologist in Baltimore, Maryland. Dr. Tkaczuk is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Tkaczuk is currently accepting new patients.

Lorraine Tafra is a General Surgeon in Annapolis, Maryland. Dr. Tafra is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy.

Christopher Gallagher is a Hematologist Oncology specialist and a Hematologist in Berlin, Maryland. Dr. Gallagher is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer.

Theodore Tsangaris is a General Surgeon in Prince Frederick, Maryland. Dr. Tsangaris is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, Mastectomy, and Lymphadenectomy. Dr. Tsangaris is currently accepting new patients.

Kristen Fernandez is a General Surgeon in Baltimore, Maryland. Dr. Fernandez is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy. Dr. Fernandez is currently accepting new patients.

Surupa Sen Gupta is a General Surgeon and a Surgical Oncologist in Bethesda, Maryland. Dr. Sen Gupta is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, and Giant Mammary Hamartoma. Dr. Sen Gupta is currently accepting new patients.

Noeline Rajarajan is a General Surgeon in Baltimore, Maryland. Dr. Rajarajan is rated as an Advanced provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Lump, and Intraductal Papilloma. Dr. Rajarajan is currently accepting new patients.

Md Siddiqui is a Hematologist Oncology specialist and a Hematologist in Salisbury, Maryland. Dr. Siddiqui is rated as an Advanced provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Pulmonary Embolism, Inflammatory Breast Cancer, Angiosarcoma, and Childhood Iron Deficiency Anemia. Dr. Siddiqui is currently accepting new patients.

Leisha Emens is an Oncologist in Baltimore, Maryland. Dr. Emens is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Ovarian Cancer.

Dr. Melissa Camp is the lead breast surgeon in the Johns Hopkins Kimmel Cancer Center's Breast Program at Green Spring Station. As the lead breast surgeon, Dr. Camp works closely with experts from medical oncology, radiation oncology, imaging and pathology to deliver comprehensive multidisciplinary breast cancer care to patients in a convenient community setting. Dr. Camp specializes in providing compassionate breast cancer treatment, including nipple-sparing mastectomy and breast conservation surgery, and helping newly-diagnosed patients navigate the decision-making process. She sees patients at The Johns Hopkins Hospital and at Johns Hopkins Health Care & Surgery Center - Green Spring Station. Dr. Camp received her bachelor’s degree in biochemistry/molecular biology summa cum laude from Dartmouth College. She graduated from the Johns Hopkins University School of Medicine and went on to complete residencies in general surgery and preventive medicine and to earn a master's degree in public health from the Johns Hopkins Bloomberg School of Public Health. As a member of the American Society of Breast Surgeons and the Society of Surgical Oncology, Dr. Camp has published several peer-reviewed journal articles and has presented her work at national and international medical meetings. Dr. Camp is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Subareolar Abscess, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy.

Dr. Rima Jean Couzi is a cancer specialist in Towson, Maryland, caring for patients with breast cancer. Dr. Couzi earned her medical degree at the National University of Ireland. She completed residencies at St. Laurence's Hospital/Beaumont Hospitals and Galway Regional in Dublin, as well as Franklin Square Hospital in Baltimore. She performed a fellowship in medical oncology at St. Vincent's Hospital and St. James's Hospital in Dublin, and an additional fellowship in medical oncology at Johns Hopkins Oncology Center in Baltimore. She also earned a master’s degree in clinical epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Couzi joined the Johns Hopkins faculty in 2004. Dr. Couzi is a member of the American Society of Clinical Oncology and the Royal College of Physicians in Ireland. Selected Publications Antonarakis ES, Fradin JM, Petronis JD, Couzi RJ. “Not What It Seems.” Am J Med. 2007;120:408-411 Holdhoff M, Wung PK, Petronis J, Couzi R. “Persistent PET-positive liver lesions after successful chemotherapy in a patient with mediastinal seminoma.” J. Clin Oncol. 2007;25:2482-4. Li S, Couzi RJ, Thomas GH, Friedman AD, Borowitz MJ. “A novel variant three-way translocation of inversion 16 in a case of AML-M4eo following low dose methotrexate therapy.” Cancer Genet Cytogenet. 2001; 125:74-7. Schultz MJ, Tabb RD, Eagan JW, Citron JR, Couzi RJ. “Treating a male breast cancer patient with moderately differentiated, infiltrating ductal cancer of the breast.” Journal of Multidisciplinary Cancer Care. 2009 September – October. Siegelbaum MH, Citron JR, Eagan JW, Couzi RJ. “Treating a patient with Unfavorable-risk prostate cancer.” Journal of Multidisciplinary Cancer Care. 2009; July – August. Dr. Couzi is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Dr. Susan Bahl, MD, FACS, is a distinguished Breast Surgeon who recently joined Johns Hopkins, practicing at both Howard County Medical Center and Johns Hopkins Bayview Medical Center. A strong advocate for women's health, Dr. Bahl brings over a decade of experience in providing state-of-the-art, evidence-based breast care within multidisciplinary settings. She has a passion for delivering personalized treatment plans to patients, specializing in both benign and malignant breast diseases. Before joining Johns Hopkins, Dr. Bahl served as the Medical Director of the Frederick Health Breast Center, where she founded a NAPBC-accredited multidisciplinary breast cancer clinic. In this role, she helped streamline the treatment process for newly diagnosed breast cancer patients by coordinating care between breast surgeons, medical oncologists, and radiation oncologists. Dr. Bahl also co-directed a Breast Screening and Prevention Program designed for high-risk women, integrating genetic testing, risk-reduction surgeries, and chemo-prevention strategies. Her commitment to patient-centered care and leadership in breast health make her a valuable addition to the Johns Hopkins community. Dr. Bahl is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy.

"Dr. Fariba Asrari is the director of Johns Hopkins Breast Center at Green Spring Station. She received her medical degree with honors from Shiraz Medical School in Iran and completed Internal medicine residency training at affiliated Hospitals of University of Pennsylvania in Philadelphia. She then completed her second residency training in Radiation Oncology at Hahnemann university in Philadelphia. She is an active member of the American Society for Therapeutic Radiology and Oncology as well as the American Medical Association, American Radium Society, Mid-Atlantic Society of Radiation Oncologists and American Society of Clinical Oncology. She is the treasurer of Mid-Atlantic Society of Radiation Oncologists. Dr. Asrari's special interest is in breast and gynecologic malignancies as well as skin cancer. She also participates in resident and medical student teaching. She is the recipient of 2006 Director's Teaching Award in Clinical Science at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and 2006 ""Teacher of The Year Award"" of Association of Residents in Radiation Oncology. She also has received 2005 Thomas Fercoit Memorial Professional of The Year Award from ""The ARC of Baltimore"" in appreciation of her dedicated care of individuals with developmental disabilities. Make A Gift". Dr. Asrari is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Prostate Cancer, Merkel Cell Carcinoma, and Angiosarcoma.